Systematic review article accepted for publication
A publication titled, “Benefit-Risk of Coffee Consumption and All-Cause Mortality: A Systematic Review and Disability Adjusted Life Year Analysis,” by ToxStrategies authors Candace… read more
Latest News
EpidStrategies announces seven new publications of RSV research
Several EpidStrategies scientists are among the collaborating authors of seven new studies on respiratory syncytial virus (RSV) published in a special supplement to… read more
Congratulations to Dr. John Rogers on the RDTSS Scientific Achievement Award
The Reproductive and Developmental Toxicology Specialty Section of the Society of Toxicology recently awarded its Scientific Achievement Award to ToxStrategies Senior Consultant Dr…. read more
Assessment of per- and polyfluoroalkyl substances (PFAS)
Concerns about potential health risks associated with low-level exposures to PFAS, along with their widespread uses and reported detections in various environmental media… read more
Cross-discipline team publishes on Cr(VI) in air
A team of ToxStrategies and EpidStrategies scientists are authors on a manuscript being published in Regulatory Toxicology and Pharmacology. The study examines current… read more
New study looks at chemotherapy dose intensity
EpidStrategies scientists Dr. Jon Fryzek, Ms. Lauren Bylsma, and colleagues, have published a paper assessing one of the key elements of chemotherapy for… read more
EpidStrategies participating in European Hematology Association 2021
EpidStrategies, a division of ToxStrategies, Inc., is excited to be participating in the European Hematology Association Virtual Congress, which will be held virtually from… read more
ToxStrategies Welcomes John M. Rogers, Ph.D.
ToxStrategies is pleased to announce that John M. Rogers, Ph.D., has joined our Health Sciences Practice, following a distinguished career with the U.S…. read more
New RSV article accepted by The Journal of Pediatrics
Ms. Mina Suh, along with colleagues within EpidStrategies (a Division of ToxStrategies), and external collaborators, has been conducting research on respiratory syncytial virus (RSV), especially as it relates to infants and children in the United States. In a prospective viral surveillance study, which was recently accepted… read more
EpidStrategies staff present RSV research at conferences
The team of epidemiologists at EpidStrategies (a Division of ToxStrategies), along with colleagues in industry and academia, have been deeply involved in ongoing research on respiratory syncytial virus (RSV) in… read more